Evidence map›Paper›PMID 30456475›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2019

Kirstin A Zettlitz, Richard Tavaré, Wen-Ting K Tsai, Reiko E Yamada, Noel S Ha, Jeffrey Collins, R Michael van Dam, John M Timmerman, Anna M Wu

Open access · greenAbstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Reengineered Anti-CD4 Cys-diabody Variants forMolecular imaging and biology · 2025
    Article
  3. Review
  4. Engineered Antibodies as Cancer Radiotheranostics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  5. SyntheticRSC medicinal chemistry · 2024
    Review
  6. Antibody Engineering for Nuclear Imaging and Radioimmunotherapy.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Article
  7. Review
  8. Review
  9. Preclinical Evaluation ofMolecular imaging and biology · 2021
    Article
  10. Imaging in Tumor Immunology.Nuclear medicine and molecular imaging · 2021
    Review
  11. Review
  12. Noninvasive Evaluation of CD20 Expression UsingJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021
    Article
  13. Review
  14. Frontiers in immunology · 2020
    Review
  15. Review
  16. On-demand radiosynthesis ofRSC advances · 2019
    Article
  17. A Dual-Modality Linker Enables Site-Specific Conjugation of Antibody Fragments forJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2019
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kirstin A ZettlitzCrump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, 90095, USA. kzettlitz@coh.org.ORCID 0000-0003-4870-6603
Richard TavaréCrump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
Wen-Ting K TsaiCrump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
Reiko E YamadaDivision of Hematology & Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
Noel S HaCrump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
Jeffrey CollinsCrump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
R Michael van DamCrump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
John M TimmermanDivision of Hematology & Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
Anna M WuCrump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
University of California, Los Angeles · USCity Of Hope National Medical Center · US

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
Multifunctional immunoPET tracers for pancreatic and prostate cancerR01CA174294 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI REITER, ROBERT E, WU, ANNA M · 2013 to 2020
$3.3M
Antibody-CpG conjugates for the treatment of B cell lymphomaR01CA149254 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TIMMERMAN, JOHN M · 2010 to 2014
$1.5M
High-throughput radiochemistry platform for accelerated discovery and development of novel PET imaging agents for cancerR21CA212718 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VAN DAM, ROBERT MICHAEL · 2017 to 2018
$616k
NCI NIH HHS P30 CA016042NCI NIH HHS R01 CA149254NCI NIH HHS R01 CA174294NCI NIH HHS R21 CA212718NIH HHS CA016042NIH HHS CA149254NIH HHS CA212718
6 · The paper itself

Abstract

purposeMetabolic imaging using [

methodsGAcDb was radiolabeled using amine-reactive N-succinimidyl 4-[

resultsThe GAcDb was successfully

conclusions[

Indexed as

Fluorine RadioisotopesAnimalsAntibodiesAntigens, CD20HumansIsotope LabelingLymphoma, B-CellMiceMice, TransgenicPositron-Emission TomographyRadiochemistryTime FactorsTissue DistributionAntibodiesAntigens, CD20Fluorine-18Fluorine Radioisotopes18FAntibody fragmentsAnti-CD20 cys-diabodyB cell lymphomaImmunoPETSame-day imaging

Identifiers

PMID30456475
PMCPMC6580847
OpenAlexW2901399581

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.